<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03374306</url>
  </required_header>
  <id_info>
    <org_study_id>HongKongPU_Optometry1</org_study_id>
    <nct_id>NCT03374306</nct_id>
  </id_info>
  <brief_title>Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate</brief_title>
  <official_title>Treatment Effect of Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate as Classified by Electro-retinal Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our project is a 24-month longitudinal randomized controlled trial that aims to investigate
      the myopia development after topical application of 0.01% atropine in children with either
      fast or slow myopia progression classified according to their initial electro-retinal
      responses. This will help elucidate the effectiveness of using low concentration atropine for
      myopia control in children with different myopia progression rates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive errors</measure>
    <time_frame>up to 18 months</time_frame>
    <description>Refractive errors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial length</measure>
    <time_frame>up to 18 months</time_frame>
    <description>Size of the eyeball</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Atropine 0.01%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receiving atropine treatment for 18 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Artifical tear</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group receiving placebo for 18 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine (0.01%)</intervention_name>
    <description>tropical application</description>
    <arm_group_label>Atropine 0.01%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Artificial tear</intervention_name>
    <description>tropical application</description>
    <arm_group_label>Artifical tear</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 7 and 10 years

          -  Good general health and no family history of ocular diseases

          -  No current or history of epilepsy or asthma

          -  Myopia : -0.50 to -1.00 D (inclusive, both eyes)

          -  Astigmatism : â‰¤ 0.50 D

          -  No hyperopia, amblyopia or strabismus

          -  No reported ocular eye diseases or disorders

          -  No drug allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry HL CHAN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henry HL CHAN, PhD</last_name>
    <phone>85217667937</phone>
    <email>henryhl.chan@polyu.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lydia YU, PhD</last_name>
    <phone>85234002911</phone>
    <email>lydia.yu@polyu.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Optometry, Hong Kong Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <zip>00000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry HL Chan, PhD</last_name>
      <phone>85227667937</phone>
      <email>henryhl.chan@polyu.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Lydia Yu, PhD</last_name>
      <phone>85234002911</phone>
      <email>lydia.yu@polyu.edu.hk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>December 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2017</study_first_posted>
  <last_update_submitted>January 22, 2018</last_update_submitted>
  <last_update_submitted_qc>January 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Henry HL Chan, PhD</investigator_full_name>
    <investigator_title>Association Professor</investigator_title>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>Myopia control</keyword>
  <keyword>Atropine</keyword>
  <keyword>Electroretinogram</keyword>
  <keyword>Multifocal Electroretinogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

